Skip to content
healthcare.dev

Olanzapine

NDC 0093-5245, Olanzapine, tablet, orally disintegrating, from Teva Pharmaceuticals USA, Inc..

Product NDC
0093-5245
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077243
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0093-5245 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLANZAPINE5 mg/1

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
0093-5245-650009352456530 BLISTER PACK in 1 CARTON (0093-5245-65) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (0093-5245-19)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dd0b2525-4e2f-44fc-9302-0ae4ebb1e135
  • NADAC price for package 00093524565

    GET /v1/drugs/nadac/00093524565

Use it

Look up 0093-5245 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0093-5245 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0093-5245. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.